5th May 2003

Exceeding Expectations

Richmond Pharmacology’s first year audited accounts showed a healthy profit and increased study placements over original projections.

Commenting on the financial results for 2002, Jörg Täubel Managing Director, stated:

“It has been an excellent year for Richmond Pharmacology. The level of bookings for trials has continued to grow throughout our first year, and we have doubled our capacity for volunteers accordingly. We are delighted to announce that at the end of our first year of trading we exceeded all expectations in terms of studies completed and by showing profitability.

“With good order books and detailed plans to accommodate more trials through the coming year, we are well positioned for another year of profitable growth for Richmond Pharmacology.”

Back to archive